OBJECTIVES: To describe the association between renal disease and other features of the metabolic syndrome and its derivative illnesses among Australian Aborigines in remote settings. METHODS: Volunteering adults (N = 2019) in four remote communities were screened for risk factors and markers of renal disease, hypertension, and diabetes, and their cross-sectional associations were evaluated. Rates of the metabolic syndrome were estimated in one community with comprehensive screening data. The associations of albuminuria with hospitalizations, coronary heart events, and non-renal deaths were then followed for > 7 years in that same community. RESULTS: Rates of renal disease, hypertension, and diabetes all increased dramatically with age. They all overlapped. Renal disease and hypertension were the most prominent and earliest features of the syndrome, while diabetes was a later, less common and more variable manifestation. All were strongly correlated with waist measurements, and high waist measurements more comprehensively characterized those with illnesses than did the more restrictive definitions of the metabolic syndrome. Albuminuria predicted non-renal hospitalizations, first time coronary heart disease events, and all-cause death. CONCLUSION: Albuminuria/proteinuria is an early and dominant element of a symptom complex that is marked by higher waist measurements, and it strongly predicts all-cause and cardiovascular illnesses and deaths. This finding implies a common background of risk factors for renal disease, hypertension, diabetes, and cardiovascular risk. The findings support integrated, rather than disease-specific, surveillance programs, an important role for albuminuria in predicting non-renal risk, and a unified approach for primary and secondary prevention of all elements of the syndrome.
OBJECTIVES: To describe the association between renal disease and other features of the metabolic syndrome and its derivative illnesses among Australian Aborigines in remote settings. METHODS: Volunteering adults (N = 2019) in four remote communities were screened for risk factors and markers of renal disease, hypertension, and diabetes, and their cross-sectional associations were evaluated. Rates of the metabolic syndrome were estimated in one community with comprehensive screening data. The associations of albuminuria with hospitalizations, coronary heart events, and non-renal deaths were then followed for > 7 years in that same community. RESULTS: Rates of renal disease, hypertension, and diabetes all increased dramatically with age. They all overlapped. Renal disease and hypertension were the most prominent and earliest features of the syndrome, while diabetes was a later, less common and more variable manifestation. All were strongly correlated with waist measurements, and high waist measurements more comprehensively characterized those with illnesses than did the more restrictive definitions of the metabolic syndrome. Albuminuria predicted non-renal hospitalizations, first time coronary heart disease events, and all-cause death. CONCLUSION:Albuminuria/proteinuria is an early and dominant element of a symptom complex that is marked by higher waist measurements, and it strongly predicts all-cause and cardiovascular illnesses and deaths. This finding implies a common background of risk factors for renal disease, hypertension, diabetes, and cardiovascular risk. The findings support integrated, rather than disease-specific, surveillance programs, an important role for albuminuria in predicting non-renal risk, and a unified approach for primary and secondary prevention of all elements of the syndrome.
Authors: Leigh Haysom; Rita Williams; Elisabeth Hodson; Pamela Lopez-Vargas; L Paul Roy; David Lyle; Jonathan C Craig Journal: Pediatr Nephrol Date: 2008-09-25 Impact factor: 3.714
Authors: Louise J Maple-Brown; Joan Cunningham; Allison M Hodge; Tarun Weeramanthri; Terry Dunbar; Paul D Lawton; Paul Z Zimmet; Steve J Chadban; Kevan R Polkinghorne; Jonathan E Shaw; Kerin O'Dea Journal: BMC Public Health Date: 2011-05-19 Impact factor: 3.295
Authors: Simon H Jiang; Sevcan Mercan; Ilenia Papa; Max Moldovan; Giles D Walters; Mark Koina; Mitali Fadia; Maurice Stanley; Tom Lea-Henry; Amelia Cook; Julia Ellyard; Brendan McMorran; Madhivanan Sundaram; Russell Thomson; Pablo F Canete; Wendy Hoy; Holly Hutton; Monika Srivastava; Kathryn McKeon; Iñigo de la Rúa Figueroa; Ricard Cervera; Raquel Faria; Sandra D'Alfonso; Mariele Gatto; Vicki Athanasopoulos; Matthew Field; John Mathews; Eun Cho; Thomas D Andrews; A Richard Kitching; Matthew C Cook; Marta Alarcon Riquelme; Melanie Bahlo; Carola G Vinuesa Journal: Cell Rep Med Date: 2021-12-21
Authors: John A Woods; Judith M Katzenellenbogen; Patricia M Davidson; Sandra C Thompson Journal: BMC Cardiovasc Disord Date: 2012-11-01 Impact factor: 2.298